Stock Market News

Sarepta stock faces FDA scrutiny after liver failure deaths

Jun 25, 2025 - 12:42
 0
Sarepta stock faces FDA scrutiny after liver failure deaths
Read More

Tags:

Previous Article

Sangamo stock holds Buy rating at H.C. Wainwright on Fabry therapy data

Next Article

H.C. Wainwright reaffirms Transcat stock rating with $116 price target

Related Posts

RWE stock rises after signing strategic framework agreement with AWS

RWE stock rises after signing strategic framework agree...

Jun 13, 2025  0

Goldman says hedge funds are buying U.S. tech stocks at...

Jun 2, 2025  0

Airbus seals VietJet deal as hopes rise at air show for tariff rollback

Airbus seals VietJet deal as hopes rise at air show for...

Jun 17, 2025  0